Citi slashes Bitcoin price target to $82K, drops ETF inflow outlook » CoinEagle
Key Points
- Citigroup cut Bitcoin and Ethereum 12-month targets, citing weaker demand and ETF flow slowdown.
- Bank reduced assumed crypto ETF inflows to zero, reflecting structural demand reassessment.
Citigroup lowered its 12-month price target for Bitcoin (BTC) to $82,000 from $112,000 and for Ethereum (ETH) to $2,240 from $3,175 in a July 1, 2026 research note.
The revision also reduces the bank’s projected net spot crypto ETF inflows over the next year to zero, down from an earlier $10 billion estimate.
This marks the firm’s second downgrade cycle in 2026 and reflects a reassessment of institutional demand assumptions rather than a routine adjustment tied solely to macroeconomic conditions.
At the time of the update, Bitcoin was trading near $58,650, down 1.2% over 24 hours, with daily volume exceeding $34.6 billion.
Drivers Behind the Forecast Cut
Citigroup attributed the revised outlook to weaker investor appetite for digital assets, negative spot Bitcoin ETF flows, and limited progress on U.S. digital asset legislation.
The bank described ETF flows as a key price driver, noting that year-to-date spot Bitcoin ETF inflows stood at approximately $3.3 billion and had recently turned negative.
By eliminating its prior assumption of $10 billion in net ETF inflows, the bank adjusted the demand inputs within its valuation framework, resulting in lower projected price support.
Legislative developments remain another variable in the bank’s outlook, particularly ongoing delays surrounding proposed U.S. digital asset market structure legislation.
Earlier in 2026, similar concerns about political delays were cited as a factor behind previous target reductions.
Revised Targets and Bear-Case Scenarios
The updated projection continues a downward sequence, with Bitcoin’s target reduced from $143,000 earlier in the year to $112,000, and now to $82,000.
Ethereum’s forecast followed a similar path, moving from $4,304 to $3,175 and then to $2,240.
The bank also adjusted its recessionary bear-case scenarios, lowering Bitcoin’s downside level from $58,000 to $53,000 and Ethereum’s from $1,198 to $1,094.
These downside revisions assume continued ETF outflows alongside softer macroeconomic conditions.
Future forecast changes may depend on developments in U.S. legislative proceedings or a sustained shift in spot ETF flow trends.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

